Abstract

The accumulation in vital organs of amyloid fibrils made of mutational variants of lysozyme (HuL) is associated with a human systemic amyloid disease. The detailed comparison of the in vitro properties of the I56T and D67H amyloidogenic variants to those of the T70N non-amyloidogenic variant and the wild-type (WT) protein suggested that the deposition of large amounts of aggregated disease-related lysozyme variants is initiated by the formation of transient intermediate species. The ability to populate such intermediates is essentially due to the destabilisation of the protein and the loss of the global structural cooperativity under physiologically relevant conditions. Here, we report the characterisation of a third naturally occurring amyloidogenic lysozyme variant, W64R, in comparison with the I56T and WT proteins. The X-ray crystal structure of the W64R variant at 1.15 Å resolution is very similar to that of the WT protein; a few interactions within the β-domain and at the interface between the α- and β-domains differ, however, from those in the WT protein. Consequently, the W64R mutation destabilizes the protein to an extent that is similar to that observed for the I56T and D67H mutations. The ΔG°NU(H2O) is reduced by 24 kJ·mol−1 and the Tm is about 12 °C lower than that of the WT protein. Under native conditions, the W64R and I56T proteins are readily digested by proteinase K, while the WT protein remains intact. These results suggest that the two variant proteins transiently populate similar partially unfolded states in which proteinase K cleavage sites are accessible to the protease. Moreover, the in vitro aggregation properties of the W64R protein are similar to those of the I56T variant. Altogether, these results indicate that the properties of the W64R protein are astonishingly similar to those of the I56T variant. They further corroborate the idea that HuL variants associated with the disease are those whose stability and global structural cooperativity are sufficiently reduced to allow the formation of aggregation prone partially folded intermediates under physiological conditions.

Highlights

  • Human lysozyme (HuL) is a bacteriolytic enzyme present in various tissues and body fluids including the liver, cartilage, saliva, tears and plasma [1,2]

  • The aggregation of a series of mutational variants of HuL into amyloid fibrils is causative of lysozyme amyloidosis (ALys), a rare autosomal dominant hereditary systemic amyloidosis

  • We report the production of the W64R protein into P. pastoris and we characterize the in vitro properties in terms of structure, stability and aggregation propensity in comparison to those of wild-type HuL (WT-HuL) and of the I56T amyloidogenic variant

Read more

Summary

Introduction

Human lysozyme (HuL) is a bacteriolytic enzyme present in various tissues and body fluids including the liver, cartilage, saliva, tears and plasma [1,2]. ALys was first identified in 1993 in two unrelated English families by Pepys and co-workers They discovered that the lysozyme gene of the affected members of each family carried an heterozygous point mutation [5]. No W64R protein was detected in the urine and plasma of the patients, under conditions where the wild-type pro­ tein was readily purified and characterized [6] These results suggested that the W64R protein is present at a very low concentration in these bodily fluids. In agree­ ment with its possible low in vivo stability, the W64R protein could not be expressed as a heterologous protein in Aspergillus niger, while the I56T, D67H and WT lysozyme could [6] These observations suggest that in vivo processing and turn-over of the W64R protein significantly differs from those of the previously characterized I56T and D67H amyloid variants [6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.